Santalis Pharmaceuticals

Santalis Pharmaceuticals, Inc. is a wholly-owned subsidiary of TFS Corporation, Ltd. (ASX: TFC). Santalis Pharmaceuticals is developing scientifically and clinically validated over-the-counter and prescription products that utilize TFS's pharmaceutical-grade East Indian sandalwood oil.Currently, Santalis is studying EISO-based drug candidates in several Phase 2 clinical trials in Australia and the United States for the treatment of infectious diseases such as psoriasis, warts, and atopic dermatitis (eczema).